RCT in 50 adults with PTSD: fMRI-guided 1-Hz TMS reduced right amygdala threat reactivity vs sham but not skin conductance reactivity (co-primary). Secondary: no group difference in PTSD symptoms after treatment, but fewer symptoms with active TMS at 3-6 months.
RCTn = 50
van Rooij et al. Personalized fMRI-Guided TMS Targeting the Threat Neurocircuitry in PTSD: A Randomized Clinical Trial